Cellectis Valuation
| CMVLF Stock | USD 4.40 0.00 0.00% |
At this time, the firm appears to be fairly valued. Cellectis SA shows a prevailing Real Value of $4.56 per share. The current price of the firm is $4.4. Our model approximates the value of Cellectis SA from analyzing the firm fundamentals such as Shares Outstanding of 55.59 M, operating margin of (6.01) %, and Return On Equity of -0.56 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Cellectis' price fluctuation is somewhat reliable at this time. Calculation of the real value of Cellectis SA is based on 3 months time horizon. Increasing Cellectis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellectis pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cellectis SA. Since Cellectis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellectis Pink Sheet. However, Cellectis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.4 | Real 4.56 | Hype 4.4 |
The real value of Cellectis Pink Sheet, also known as its intrinsic value, is the underlying worth of Cellectis SA Company, which is reflected in its stock price. It is based on Cellectis' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cellectis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cellectis SA helps investors to forecast how Cellectis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellectis more accurately as focusing exclusively on Cellectis' fundamentals will not take into account other important factors: About Cellectis Valuation
The pink sheet valuation mechanism determines Cellectis' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cellectis. We calculate exposure to Cellectis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellectis's related companies.Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. Cellectis Romainvil operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 294 people.
8 Steps to conduct Cellectis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cellectis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cellectis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cellectis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cellectis' revenue streams: Identify Cellectis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cellectis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cellectis' growth potential: Evaluate Cellectis' management, business model, and growth potential.
- Determine Cellectis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cellectis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cellectis Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cellectis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 45.5 M | |
| Retained Earnings | -698.3 M |
Complementary Tools for Cellectis Pink Sheet analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |